The morphology and porosity of zeolite play a significant role in the activity and selectivity of catalytic reactions. It is a dream to optionally modulate zeolite morphology by regulating the crystallization process on the basis of comprehensively understanding the mechanisms. Herein, a series of MTW zeolite mesocrystals can be consciously fabricated with morphologies from a dense structure to a loose one of an oriented nanocrystallite aggregate by changing the H 2 O/SiO 2 ratio. Their intertwined classical/nonclassical crystallization processes are investigated comprehensively. The results indicate that the crystallization of MTW zeolite takes place by a chain of events, including the formation of wormlike particles (WLPs), their aggregation, and crystallization of aggregates. MTW with a loose structure mainly crystallizes by an internal reorganization after a fast aggregation of WLPs in a concentrated system. On the other hand, the dense structure of MTW is realized via the co-occurrence of a coalescence of the participating WLPs during its crystal growth with a slower rate in a dilute system. Moreover, the advantages of MTW with a loose structure are confirmed through cumene cracking and 1,2,4trimethylbenzene transformation. This method could pave the way for the synthesis of other zeolites with diverse morphologies and/or mesoporosities via subtle regulation of the crystallization pathway.
The superior propylene yield of the In2O3-beta composite (ca. 50%) for the conversion of ethanol to propylene compared to In2O3 (ca. 32%) is due to the fact that zeolite beta in the composite enhances the conversion of the intermediate of acetone to propylene via an additional pathway.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.